Work

Risk of Dermatologic Toxicity to Radiation Therapy (RT) Plus Epidermal Growth Factor Receptor Inhibitor (EGFRI) Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)

FWCI:
Cites:
Cited by:
Related to: 10